qEEG Brain Signature of Depression & Neuromodulation-induced Recovery

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2028

Conditions
Major Depressive Diorder
Interventions
DEVICE

Transcranial Magnetic Stimulation

rTMS is a non-invasive brain stimulation that uses magnetic fields to stimulate specific areas of the brain. It is commonly used for the treatment of neurological and psychiatric disorders, such as major depressive disorder (MDD), anxiety, and sometimes ALS.

Trial Locations (2)

M4N 3M5

NOT_YET_RECRUITING

Sunnybrook Health Sciences Centre, North York

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mitacs

INDUSTRY

collaborator

iMediSync

UNKNOWN

lead

Sunnybrook Health Sciences Centre

OTHER

NCT06719427 - qEEG Brain Signature of Depression & Neuromodulation-induced Recovery | Biotech Hunter | Biotech Hunter